Canada approves AstraZeneca’s COVID-19 vaccine

AstraZeneca COVID-19 vaccine

Health Canada today approved the COVID-19 vaccine from AstraZeneca making it the third Vaccine in Canada to be approved from Pfizer and Moderna. Canada has reserved 20 million doses of the AstraZeneca #COVID19 vaccine — enough to vaccinate 10 million people. The AstraZeneca Vaccine as per the clinical trials is less effective with a protection rate of 62 percent versus high 90s — but offers distinct benefits, including that it can be stored and transported at normal refrigerated temperatures. To date in Canada has, 972,407 people (2.56% of the population) have received at least one dose of a COVID-19 vaccine, of which 665,189 people (1.75% of the population) have received only one dose and 307,218 people (0.81% of the population) have received two doses.

The Pfizer-BioNTech COVID-19 vaccine was authorized for use in Canada on December 9, 2020. The Moderna COVID-19 vaccine was authorized for use in Canada on December 23, 2020.

Health Canada is also reviewing two other vaccines including One shot Johnson & Johnson’s Janssen and Novavax.

Total Vaccine administered till data in Canada: 1,707,398

Ontario: 621,960

Quebec: 387,076

British Columbia: 239,883

Nunavut: 7,257

Alberta: 195,572

Nova Scotia: 30,748